SCHEMBL29520989

SCHEMBL29520989

COCn1ncc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.56
CYP1A2 P05177 1/20 0.51
KMO O15229 1/20 0.50
HSD17B10 Q99714 3/20 0.45
POLB P06746 3/20 0.45
TSHR P16473 2/20 0.45
CHRM2 P08172 3/20 0.44
CHRM1 P11229 3/20 0.44
ADRA2A P08913 1/20 0.44
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
DAO P14920 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 1/20 0.41
P2RX7 Q99572 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5946299 0.82 CYP1A2 (0.57) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL29354552 0.80 CYP1A2 (0.54) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL13217 0.79 RECQL (0.61) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL16617269 0.77 CYP1A2 (0.41) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL323712 0.77 RECQL (0.51) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL29365472 0.77 RECQL (0.47) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL27718799 0.77 RECQL (0.47) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL7331551 0.76 RECQL (0.69) RECQLCYP1A2KMOHSD17B10POLB
SCHEMBL29037804 0.76 KMO (0.55) KMOHSD17B10TSHRCHRM2CHRM1
SCHEMBL29520376 0.76 KMO (0.55) KMOHSD17B10TSHRCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216316-A1 DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTIC BUCK INST RES AGING (US) 2024-07-04 US disclosed
US-11649255-B2 Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same 1ST Biotherapeutics, Inc. (KR) 2023-05-16 US disclosed
US-20220098193-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS USING SAME 1ST Biotherapeutics, Inc. 2022-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11649255-B2 Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same IP6K1, HIPK1, IP6K3 RECQL 1162/4885CYP1A2 1840/4885KMO 1689/4885
US-20220098193-A1 INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS USING SAME IP6K1, HIPK1, IP6K3 RECQL 1162/4885CYP1A2 1840/4885KMO 1689/4885
US-20240216316-A1 DIHOMO-GAMMA LINOLENIC ACID (DGLA) IS A NOVEL SENOLYTIC DAGLA, DAGLB, MGLL RECQL 476/4885CYP1A2 3697/4885KMO 2760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.